WCN24-555 PHARMACOKINETICS OF SINGLE DOSES OF IPTACOPAN by Robert Schmouder, Guido Junge, Prasanna Kumar Nidamarthy, Kenneth Kulmatycki

Get full text

WCN24-748 ASSESSMENT OF THE EFFECT OF HEPATIC IMPAIRMENT ON IPTACOPAN PHARMACOKINETICS by Robert Schmouder, Kenneth Kulmatycki, Elise Burmeister Getz, Wendy Weiss, Bharti Shah

Get full text

WCN24-750 ASSESSMENT OF DRUG INTERACTIONS WITH IPTACOPAN by Robert Schmouder, Kenneth Kulmatycki, Bharti Shah, Amanda Taylor, Prasanna Kumar Nidamarthy

Get full text

WCN24-550 SINGLE DOSE OF IPTACOPAN TREATMENT RAPIDLY DESCREASES PLASMA COMPLEMENT Bb LEVELS by Robert Schmouder, Guido Junge, Julie Milojevic, Prasanna Kumar Nidamarthy, Kenneth Kulmatycki

Get full text

WCN25-797 SAFETY AND EFFICACY OF IPTACOPAN IN PATIENTS WITH IgA NEPHROPATHY (IgAN) WITH BASELINE eGFR 20-<30 mL/MIN: PHASE 3 APPLAUSE-IgAN SUBCOHORT RESULTS by Dmitrij Kollins, Olympia Papachristofi, Thomas Hach, Severina Jacinto-Sanders, Tobias Merkel, Robert Schmouder, Kenneth Kulmatycki, Ronny Renfurm, Vlado Perkovic

Get full text